Article List

December 30, 2025
What Happened on a Closed Mount Fuji? The Hidden Truth Behind a Fatal Fall

By Honourway Asia Pacific Limited
December 25, 2025
In Memoriam: Masashi “Jumbo” Ozaki — The 113-Win Path of Supremacy Left by the “Samurai of the Showa Era,” and His Legacy Passed to the Next Generation

By Honourway Asia Pacific Limited
December 22, 2025
Prime Minister Takaichi Opens a “New Silk Road”: Envisioning Central Asia’s Future with ¥3 Trillion

By Honourway Asia Pacific Limited
December 19, 2025
Sony Acquires Snoopy Parent Company to Strengthen Its IP Portfolio

By Honourway Asia Pacific Limited
December 17, 2025
Inbound Visitors Surpass 39 Million: Japan’s Tourism Boom—and a Turning Point for a “Tourism Nation”

By Honourway Asia Pacific Limited
December 15, 2025
KAIROS Launch Vehicle No. 3 to Retry on February 25: Japan’s Private Space Sector Takes a Do-or-Die Challenge

By Honourway Asia Pacific Limited
December 15, 2025
Concerns Over Environmental Destruction: Government to End Support for Mega Solar Projects from FY2027

By Honourway Asia Pacific Limited
December 10, 2025
Thirty Minutes of Terror: Chinese Aircraft Radar Targeting and Japan’s Resolve

By Honourway Asia Pacific Limited
December 8, 2025
Aomori Offshore Earthquake: The First-Ever “Advisory Information” and Japan’s New Test

By Honourway Asia Pacific Limited
December 5, 2025
Fuji TV Secures Exclusive F1 Rights: DAZN Exits and a New Era Begins in 2026

By Honourway Asia Pacific Limited
December 2, 2025
Man With a Knife Arrested at a Disney Hotel: The Shock That Struck the “Dreamland”—and What Lies Beneath

By Honourway Asia Pacific Limited
December 2, 2025
The Shock and Hidden Depths of Chinese Cruise Ships “Avoiding Japan”

By Honourway Asia Pacific Limited
November 30, 2025
Approval for the Takaichi Cabinet Rises to 75%, Maintaining High Support

By Honourway Asia Pacific Limited
November 27, 2025
Takaichi to Begin Consideration of Anti-Spy Law Within the Year: A Major Turning Point in Japan’s Security Policy

By Honourway Asia Pacific Limited
November 24, 2025
Return from the G20: Chilled Japan–China Relations and a Crucial Test for Takaichi’s Diplomacy

By Honourway Asia Pacific Limited
November 18, 2025
500,000 Cancellations Due to China Boycott: Why Japan’s Tourism Avoids a “Fatal Blow” Despite a 2 Trillion Yen Loss

By Honourway Asia Pacific Limited
November 17, 2025
BTC Wipes Out All Year-to-Date Gains

By Honourway Asia Pacific Limited
November 13, 2025
Police to Use Rifles to Cull Bears: Japan’s New “Human vs. Beast” Strategy

By Honourway Asia Pacific Limited
November 11, 2025
PokéPark KANTO to Open in Tokyo in 2026

By Honourway Asia Pacific Limited
November 10, 2025
“A Taiwan Contingency Is a Survival-Threatening Situation”: The Shockwaves from Takaichi’s Remark

By Honourway Asia Pacific Limited

POPULAR ARTICLES

February 21, 2024
World Insight Interview by Shunsuke Ochiai Vol.1 Hillary and her story about her amazing air bnb

This interview focuses on Hillary's travels to Japan, her love of Japanese culture, and her successful entry into the Airbnb market in Ito, voted one of Japan's top lodging destinations.

By Shunsuke Ochiai
June 17, 2025
Ishiba’s G7 Debut: Diplomacy at the Crossroads of Continuity and Change

In June 2025, Prime Minister Shigeru Ishiba will make his debut on the global stage at the G7 Summit held in Canada. For Japan’s new leader, this summit will serve as the first litmus test of his diplomatic direction.

By Honourway Asia Pacific Limited
November 24, 2025
Return from the G20: Chilled Japan–China Relations and a Crucial Test for Takaichi’s Diplomacy

On the night of November 24, 2025, Prime Minister Sanae Takaichi completed all her engagements at the G20 Leaders’ Summit held in Johannesburg, South Africa, and returned to Tokyo’s Haneda Airport aboard the government aircraft.

By Honourway Asia Pacific Limited
April 8, 2025
Opening the Door to Regenerative Medicine: iPS Cardiac Muscle Sheets

On April 8, 2025, Japan’s regenerative medicine reached a historic turning point. Cuorips Inc., a biotech venture spun out of Osaka University, announced it had submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for a “cardiomyocyte sheet” created from human induced pluripotent stem (iPS) cells. This is believed to be the world’s first marketing application aiming to commercialize a regenerative medicine product using iPS cells, and it has generated great anticipation across the scientific and medical communities.

By Honourway Asia Pacific Limited

TOPICS

WORLD INSIGHT

Popular keywords